Fortune 500 Power Moves: Which executives gained and lost power this week

Fortune 500 companies announced several C-suite moves during Sept. 12-18, 2026, including Otis CEO Judy Marks' planned retirement in the first half of 2027 after a successor is appointed. Accendra Health named Kenneth Gardner-Smith CEO effective in Q4, while JLL created a COO role for Paul Morgan, Masco appointed Yaron Ben David as Chief Technology and AI Officer, and Target hired Mark Weinstein as Chief Marketing and Guest Experience Officer. The changes are primarily succession and organizational updates, with limited near-term broad market implications.

Analysis

This is principally governance noise rather than an earnings-revision event. OTIS is the only item with a potentially tradeable mechanism: a protracted external CEO search could introduce uncertainty around capital allocation, pricing discipline, and China exposure just as service-margin durability matters more than new-equipment growth. The extended transition reduces near-term operational-disruption risk, but the stock could carry a modest succession discount versus KONE Oyj or Schindler until the successor’s operating and M&A posture is known.

JLL’s operating-layer consolidation is directionally constructive if it reduces duplication across property and workplace-management platforms, where modest SG&A leverage can matter disproportionately in a cyclical commercial-real-estate recovery. The investable question is not the title change but whether 2027 guidance shows margin expansion and working-capital discipline while transaction volumes recover; absent those disclosures, this is not sufficient to underwrite a position. MAS’s dedicated technology/AI leadership similarly has a longer-dated productivity optionality, but fragmented construction demand and repair/remodel cycle direction will dominate the shares over the next 1-3 quarters.

TGT’s marketing appointment is an attempt to improve customer acquisition and brand relevance, but marketing investment can depress near-term EBIT before traffic responds. The non-obvious read-through is that a more premium, hospitality-oriented brand play may improve owned-brand mix but risks weak ROI if value-sensitive consumers remain focused on consumables and price; WMT and COST remain better positioned if discretionary demand softens. Do not infer any signal for HLT from the executive departure, and do not use ACH as a proxy for Accendra Health: ACH is Aluminum Corporation of China and appears to be an invalid ticker mapping.

Key Decisions for Investors

• Maintain a watch, not a position, in OTIS through the successor announcement. Consider a relative short OTIS / long KONE or long CARR only if OTIS underperforms peers by less than 5% despite a search extending beyond year-end; cover on an internally promoted successor with explicit service-margin and buyback continuity.
• Place JLL on a 1-3 month earnings-watch list rather than buying on the COO change. Upgrade only if forward guidance indicates sustained fee-revenue acceleration plus at least 50 bps of operating-margin expansion; falsifier is rising net working-capital use or renewed transaction-market weakness.
• Avoid treating MAS’s AI executive appointment as a standalone catalyst. Revisit a long MAS versus short HD or XHB only after evidence of lower SG&A intensity or faster dealer conversion emerges in the next two reporting periods; housing-turnover and R&R demand data remain the primary risk.
• For TGT, monitor quarterly traffic, digital conversion, and marketing expense as a percent of sales over the next 2-3 quarters. A traffic improvement without greater-than-30 bps EBIT-margin erosion would support a tactical long; continued discretionary-share loss versus WMT/COST would invalidate the turnaround premise.